New syringe aims to take the guesswork out of epidural pain relief

NCT ID NCT07654907

Not yet recruiting Symptom relief Sponsor: Flat Medical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the EpiFaith™ Syringe, which gives a clear visual signal when a doctor reaches the right spot for an epidural pain injection. Currently, doctors rely on feel alone, which can lead to multiple needle sticks or mistakes. The study will compare the new syringe to the standard method in 100 adults having epidural procedures for chronic pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EpiFaith™ Syringe (a device with a spring-loaded piston that shows a visual signal when the epidural space is reached)
What this could lead to: If it works, this device could make epidural pain procedures more accurate and less reliant on a doctor's feel, potentially reducing needle sticks and false signals.
What could go wrong: This is a small, early-stage study with only 100 people, and it is not randomized. The device may not work better than the standard method, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN

Contacts and locations

Locations

Innovative Pain Treatment Solutions

San Diego, California, 92111, United States
Innovative Pain Treatment Solutions

Temecula, California, 92590, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.